-The Times of India NEW DELHI: India's march towards being an economically stable nation is threatened not just by global financial issues. Poor health indicators pose an equally big threat. The Harvard School of Public Health has, in a study on economic losses due to non-communicable diseases (NCDs), estimated that the economic burden of these ailments for India will be close to $6.2 trillion for the period 2012-30, a figure that is...
More »SEARCH RESULT
Total Matching Records found : 112
SC notice on PIL seeking ban on ‘killer’ vaccine -Dhananjay Mahapatra
-The Times of India NEW DELHI: The Supreme Court on Monday agreed to examine a PIL alleging a sharp increase in infant deaths after administration of pentavalent vaccine, which replaced the tried and tested vaccines to fight five deadly diseases under the universal immunization programme (UIP). PIL petitioner Yogesh Jain, a former pediatrician in AIIMS and now a public health physician at Jan Swasthya Sahyog in Bilaspur district, alleged a conspiracy in...
More »Ahead of World Hepatitis Day, UN urges greater efforts to fight ‘silent epidemic’
-The United Nations Only one-third of the world's countries have national strategies for viral hepatitis, the United Nations health agency today said urging Governments to scale up measures to tackle this ‘silent epidemic,' in particular the five types that, over time, cause chronic and debilitating illnesses. "The fact that many Hepatitis B and C infections are silent, causing no symptoms until there is severe damage to the liver, points to the urgent...
More »WHO accused of promoting 'deadly' vaccine in India -KS Jayaraman
-IANS Bangalore: A leading journal of medical ethics has charged the World Health Organization (WHO) with promoting the Pentavalent vaccine in countries, including India, though it is known to have caused adverse reactions and deaths in children. In a hard-hitting editorial, the latest issue of the Indian Journal of Medical Ethics (IJME), has accused the WHO of promoting the vaccine "by stating falsely that no adverse event following immunisation (AEFI) has ever...
More »Landmark verdict -V Venkatesan
-Frontline The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...
More »
